1. DNase in stable cystic fibrosis infants: a pilot study
Maartje ten Berge, Els van der Wiel, Harm A.W.M. Tiddens, Peter J.F.M. Merkus, Wim C.J. Hop, Johan C. de Jongste 
Journal of Cystic Fibrosis 
Volume 2, Issue 4, Pages (December 2003)
DOI: /S (03)

2. Fig. 1
Changes of V′maxFRC compared to baseline following treatment with RhDNase (8 paired measurements, left panel) or NaCl 0.9% (6 paired measurements, right panel). Treatment periods: 4 weeks, (open circles), or 2 weeks (open squares); *: P<0.002, paired t-test. (RhDNase compared to saline), left panel.
Journal of Cystic Fibrosis 2003 2, DOI: ( /S (03) )

3. Fig. 2
Individual values of V′maxFRC during the study for group 1 (upper panel) and group 2 (lower panel).
Journal of Cystic Fibrosis 2003 2, DOI: ( /S (03) )